Numerous studies have shown that Alpha-beta accumulation leads to synaptic dysfunction and loss of synapses. Synaptic Alpha-beta and Alpha-beta oligomers have been strongly implicated in the progression of AD. Recent studies have demonstrated that gamma-secretase forms an active complex at synapses. However, proteins modulating synaptic APP processing remain largely unknown. We have performed two proteomic screens in mouse brain lysates to identify proteins interacting with the ectodomains of APP and nicastrin. These screens have identified synaptotagmins (Syt) 1, 2, and 9 as strong binding partners of both APP and nicastrin. Syt1 and 9 also interact with the large loop of PSI (Project 3). Sytl, 2, and 9 are type I Ca2+-sensing synaptic vesicle membrane proteins and play a major role in distinct membrane fusion events for synaptic vesicle release. Our further co-IP, EM, and in situ PLA studies demonstrated that full-length Syts bind to APP in cells and mouse brains. GST pulldown assays confirmed specific binding of Sytl to a the region surrounding the KPI domain of APP. Our preliminary data also show that overexpression of Syts increases Alpha-beta generation and ratios, by perhaps inducing p- and/or gamma-secretase-mediated processing of APP. Syt expression also increases palmitoylated APP levels. Here, we will test the hypothesis that Sytl, 2, and 9 act as physiological modulators of APP processing in neurons. Specifically, we will further explore the regulation of Syt binding to APP, dissect the contribution of Syts to Alpha-beta generation in neuronal models and will ask whether Syts affect the neuronal functions of gamma-secretase. In addition, we will also analyze the effect of novel APP-specific gamma-secretase inhibitors (Project 1) and gamma-secretase modulators (Project 2) on the neuronal functions of gamma-secretase with particular focus on synaptic proteins, and on the processing of non-APP gamma-secretase substrates. These experiments are aimed at identifying compounds lacking adverse effects commonly associated with gamma-secretase inhibitors. Our project will contribute to the overall goal of the program project in providing mechanistic data that may serve in the development of novel p- or gamma-secretase-based strategies forthe prevention and treatment of Alzheimer's disease.

Public Health Relevance

We have recently found that three synaptotagmins bind to the beta-amyloid precursor protein, thereby increasing toxic beta-amyloid production. This proposal directly tests the mechanism of how synaptotagmins modulate beta-amyloid generation in neuronal models of Alzheimer's disease and may contribute to the development of novel strategies for the prevention and treatment of the disease.

Agency
National Institute of Health (NIH)
Type
Research Program Projects (P01)
Project #
5P01AG015379-17
Application #
8738551
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Holmes, Oliver; Paturi, Swetha; Wolfe, Michael S et al. (2014) Functional analysis and purification of a Pen-2 fusion protein for ?-secretase structural studies. J Neurochem 131:94-100
McFarland, Karen N; Huizenga, Megan N; Darnell, Shayna B et al. (2014) MeCP2: a novel Huntingtin interactor. Hum Mol Genet 23:1036-44
Li, Yi; Lu, Stephen Hsueh-Jeng; Tsai, Ching-Ju et al. (2014) Structural interactions between inhibitor and substrate docking sites give insight into mechanisms of human PS1 complexes. Structure 22:125-35
Choi, Se Hoon; Kim, Young Hye; Hebisch, Matthias et al. (2014) A three-dimensional human neural cell culture model of Alzheimer's disease. Nature 515:274-8
Bolduc, David M; Wolfe, Michael S (2014) Structure of nicastrin unveils secrets of ?-secretase. Proc Natl Acad Sci U S A 111:14643-4
Winslow, Ashley R; Moussaud, Simon; Zhu, Liya et al. (2014) Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease. Brain 137:1958-70
Holmes, Oliver; Paturi, Swetha; Selkoe, Dennis J et al. (2014) Pen-2 is essential for ?-secretase complex stability and trafficking but partially dispensable for endoproteolysis. Biochemistry 53:4393-406
Kim, Doo Yeon; Wertz, Mary H; Gautam, Vivek et al. (2014) The E280A presenilin mutation reduces voltage-gated sodium channel levels in neuronal cells. Neurodegener Dis 13:64-8
Wahlster, Lara; Arimon, Muriel; Nasser-Ghodsi, Navine et al. (2013) Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer's disease. Acta Neuropathol 125:187-99
Li, Xuejing; Uemura, Kengo; Hashimoto, Tadafumi et al. (2013) Neuronal activity and secreted amyloid ? lead to altered amyloid ? precursor protein and presenilin 1 interactions. Neurobiol Dis 50:127-34

Showing the most recent 10 out of 95 publications